Antares Pharma

$3.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+2.97%) Today
+$0.03 (+0.96%) As of 7:01 AM EST after-hours

Why Robinhood?

You can buy or sell Antares Pharma and other stocks, options, and ETFs commission-free!

About ATRS

Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. The listed name for ATRS is Antares Pharma, Inc. Common Stock.

CEO
Robert F. Apple
Employees
178
Headquarters
Ewing, New Jersey
Founded
1979
Market Cap
520.02M
Price-Earnings Ratio
56.22
Dividend Yield
Average Volume
843.48K
High Today
$3.13
Low Today
$2.98
Open Price
$3.00
Volume
618.04K
52 Week High
$5.13
52 Week Low
$1.60

Collections

ATRS Earnings

-$0.04
-$0.02
$0.01
$0.03
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like